Celyad Oncology, Longeveron leads healthcare gainers; Esperion Therapeutics, Biofrontera among major losers
Dec. 03, 2021 11:09 AM ETESPR, CYADY, AIH, PTPI, LGVN, DNA, HOWL, VALN, BFRI, AIRSBy: SA News Team
-
Gainers: Celyad Oncology (NASDAQ:CYAD) +41%, Longeveron (NASDAQ:LGVN) +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies (NASDAQ:AIRS) +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%.
-
Losers: Esperion Therapeutics (NASDAQ:ESPR) -40%, Biofrontera (NASDAQ:BFRI) -17%, Ginkgo Bioworks (NYSE:DNA) -16%, Valneva SE VALN -16%, Aesthetic Medical (NASDAQ:AIH) -14%.